Dupilumab Reduction of IgE Levels and Probability of Atopic Dermatitis Flares – Analysis of A Randomized Placebo-Controlled 52-Week Study

IgE levels are often elevated in patients with atopic dermatitis (AD) but the clinical relevance of reducing IgE levels in patients with AD remains unclear. This analysis reports the impact of dupilumab treatment on total IgE levels in association with the probability of having flares in patients with moderate-to-severe AD.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research